« Back
Home /
RPMI-8226 cells

RPMI-8226 cells

Item no.	C0003002
Manufacturer	Addexbio
Amount	One Frozen vial
Category	Oncology Cell Lines & Cell Culture Cell Lines By Organ Heart & Blood Cancer Lymphatic System Cancer Bone Cancer
Type	Tumour Cells
Specific against	Human (Homo sapiens)
Dry ice	Yes
Citations	1.Genty, V., Dine, G., and Dufer, J. Phenotypical alterations induced by glucocorticoids resistance in RPMI 8226 human myeloma cells. Leuk Res, 28: 307-313, 2004. 2.Genty, V., El-Khoury, V., Liautaud-Roger, F., Dine, G., and Dufer, J. Nuclear chromatin patterns in 3 glucocorticoid-resistant RPMI 8226 human myeloma cell sub-lines: correlations with cell growth and immunological phenotype. Cancer Biol Ther, 4: 832-839, 2005. 3.Hwang, W. Y., Gullo, C. A., Shen, J., Poh, C. K., Tham, S. C., Cow, G., Au, M., Chan, E. W., and Teoh, G. Decoupling of normal CD40/interleukin-4 immunoglobulin heavy chain switch signal leads to genomic instability in SGH-MM5 and RPMI 8226 multiple myeloma cell lines. Leukemia, 20: 715-723, 2006. 4.Iijima, M., Momose, I., and Ikeda, D. Increased ABCB1 expression in TP-110-resistant RPMI-8226 cells. Biosci Biotechnol Biochem, 74: 1913-1919. 5.Lee, K. W., Kim, D. S., and Kwon, H. J. CG sequence- and phosphorothioate backbone modification-dependent activation of the NF-kappaB-responsive gene expression by CpG-oligodeoxynucleotides in human RPMI 8226 B cells. Mol Immunol, 41: 955-964, 2004. 6.Rao, P. S., Ramanadham, M., and Prasad, M. N. Anti-proliferative and cytotoxic effects of Strychnos nux-vomica root extract on human multiple myeloma cell line - RPMI 8226. Food Chem Toxicol, 47: 283-288, 2009.
ECLASS 10.1	32160890
ECLASS 11.0	32160890
UNSPSC	41106509
Available
Description	Disease: Plasmacytoma; myeloma Origin: Derived from B lymphocytes Species: Homo sapiens Tissue: Blood Morphology: Lymphoblast Properties: Suspension Cytogenic data: Unstable karyotype in triploid Patient: Male, 61 yrs of age Medium: RPMI1640 + 10% FBS Subculture: Cultures can be maintained by the addition of fresh medium or replacement of medium. Alternatively, cultures can be established by centrifugation with subsequent resuspension at 5 X 10⁵ viable cells/ml. Do not allow the cell density to exceed 2 to 3 X 10⁶ cells/ml. Culture cells at 5% CO₂, 37C. Medium Renewal: Every 2 to 3 days. Freezing Medium: Complete culture medium supplemented with 5% (v/v) DMSO Biosafety Level: I Sterility: Bacteria: Negative Yeast: Negative Mycoplasma: Negative Pathogens: HIV: Negative Hepatitis B: Negative Hepatitis C: Negative Isoenzymes: G6PD, A DNA Profile (STR): Amelogenin: X, Y; CSF1PO: 12; D13S317: 11; D16S539: 9; D5S818: 11, 13; D7S820: 9, 10; THO1: 8; TPOX: 8, 11; vWA: 16, 18 Related cells by Organ: CCRF-CEM K562 LP-1 MOLM-13 RPMI-8226 U937 RAW 264.7
Storage condition	LN2
Manufacturers Category	Cell Lines

Note: The presented information and documents (Manual, Product Datasheet, Safety Datasheet and Certificate of Analysis) correspond to our latest update and should serve for orientational purpose only. We do not guarantee the topicality. We would kindly ask you to make a request for specific requirements, if necessary.

All products are intended for research use only (RUO). Not for human, veterinary or therapeutic use.

Request Data Sheet

Request product datasheet

Request safety datasheet

Simple Order Order Subscription

Amount: One Frozen vial

available

Delivery expected until 8/28/2025

Express Delivery: Save 14 days

Compare

Add to wishlist

Get an offer